Navigation Links
Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer

Preliminary results from a large, randomized clinical trial for patients with previously untreated recurrent or metastatic breast cancer ?cancer that has spread from the breast to other parts of the body ?show that those patients who received bevacizumab (Avastin? in combination with standard chemotherapy had a longer time period before their cancer progressed than patients who received the same chemotherapy without bevacizumab.

The clinical trial was sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health, and conducted by a network of researchers led by the Eastern Cooperative Oncology Group (ECOG). Genentech, Inc., South San Francisco, Calif., which manufactures bevacizumab, provided bevacizumab for the trial under the Cooperative Research and Development Agreement (CRADA) with NCI for the clinical development of bevacizumab.

The Data Monitoring Committee overseeing the trial (known as E2100)* recommended that the results of a recent interim analysis be made public because the study had met its primary endpoint of increasing progression-free survival (the amount of time patients lived without the cancer getting worse).

Preliminary results suggest that patients in the study who received bevacizumab in combination with standard chemotherapy consisting of single-agent paclitaxel had a delay in worsening of their cancer by four months, on average, compared to patients treated with paclitaxel chemotherapy alone. This difference is statistically significant.
“This study is the first to find a benefit of anti-angiogenic therapy in patients with breast cancer and represents a major advance in the treatment of patients with metastatic disease," said Study Chair Kathy D. Miller, M.D., of the Indiana University Medical Center in Indianapolis, Ind. Anti-angiogenic drugs, also called angiogenesis inhibitors, are substances that may prevent angiogenesis, or the formation of blood vessels. In anticancer therapy, a
'"/>

Source:NIH


Page: 1 2 3

Related biology news :

1. Harmful Bacterium Commonly Found in Poultry May Survive Refrigeration and Frozen Storage Combined
2. Combined treatment extends life expectancy for lung cancer patients
3. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
4. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
5. Chemotherapy gel may fight breast cancer and reduce breast deformity
6. Chemotherapy temporarily affects the structures of the human brain
7. Cell therapy slows progression of an inherited neurological disease; Improves motor skills in mice
8. Protein That Promotes Survival Of Stem Cells Might Be Key To Poor Leukemia Prognosis
9. Survival of heart patients on beta-blockers varies greatly with genetic variation
10. Survival of the selfless - scientists find cheats dont always prosper
11. Survival of the rarest: Fruit flies shed light on the evolution of behavior
Post Your Comments:
(Date:2/5/2015)... OXFORD, Conn. , Jan. 28, 2015 ... ("NXT-ID" or the "Company"), a biometric authentication company focused ... present at the upcoming RedChip Global Online CEO Conference ... Gino Pereira , CEO of ... discussing its lead product, the Wocket smart wallet and ...
(Date:2/5/2015)... Jan. 30, 2015  It is gratifying to see ... potential for genomic science as a means to better ... and treatment.  I was honored to participate in today,s ... medicine program. Since the 1980s my ... genomics—from the first sequenced genome of a free living ...
(Date:1/22/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced ... Overview" report to their offering. , ... an individual is who she/he is claiming to be, and ... person,s unique physical characteristics, such as fingerprint, hand or palm ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
... their genes and the environment in which they grow ... other children, has less to do with genetic factors ... influence on children is friends. But while past studies ... increased physical aggression in children and teens, few studies ...
... long known that including dairy in their diets can ... loss. However, a recent study published in the January ... of the American Academy of Periodontology (AAP), demonstrated that ... periodontal health. The study analyzed the periodontal health of ...
... CAMBRIDGE, Mass.--An MIT team has used an engineering approach to ... models developed by measuring what goes into and out of ... alternative way to look at the inner workings of a ... them to study systems in their natural state. The ...
Cached Biology News:Genes and environment interact in first graders to predict physical but not social aggression 2Want healthy gums? Hit the dairy aisle 2MIT applies engineering approach to studying biological pathways 2
(Date:3/3/2015)... 3, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: APTO, ... molecular diagnostics that target the underlying mechanisms of cancer, ... period ended December 31, 2014. Effective July ... from May 31 to December 31. As a result ... are for the quarter and the seven months ended ...
(Date:3/3/2015)... Ky. (PRWEB) March 03, 2015 Experts ... their schedules for one event: the Alltech REBELation exploring ... from May 17-20. Now in its 31st year, Alltech’s ... from 70 countries, and the opportunity to join the ... March 7 at 11:59 p.m. EST, at which point ...
(Date:3/3/2015)... 3, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... President and Chief Executive Officer of Neurocrine Biosciences, will ... Miami.   The live presentation takes place ... The presentation will be webcast and may be accessed ... Listeners are encouraged to visit the website ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 ... Inc. to their international sales network. The business ... dissolution technology to Canada’s Atlantic Provinces, exclusively through ... served as one of Canada’s premiere manufacturing representative ... both the municipal water and wastewater markets. More ...
Breaking Biology Technology:Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 3World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 4BlueInGreen® Continues Canadian Expansion, Partners with Resource Systems Inc. 2
... first quarter of 2007 was not particularly exciting, although the ... Dow Jones Industrials is poised to break through the ... grain of salt. , ,The major life science indices ran ... Biotech Index showing some signs of life (if you ...
... ranks in the lower half of states in federal ... help researchers and companies land more federal security contracts. ... by a grant from the U.S. Small Business ... sensitive, classified research. , ,What we're trying to do ...
... Madison, Wis . - If manufacturers are interested in new ... a conference that provides a learning and technology transfer opportunity. ... already puts on an annual design event at the ... expanded the program with the intention of opening doors to ...
Cached Biology Technology:Midwest life science stocks sizzle in a tepid first quarter 2Midwest life science stocks sizzle in a tepid first quarter 3Midwest life science stocks sizzle in a tepid first quarter 4Midwest life science stocks sizzle in a tepid first quarter 5Research consortium aims to bring security and defense contracts to Wisconsin 2
Component in MasterPure™ Purification Kits...
Chlamydia pneumoniae (TWAR)...
Prostaglandin-E2 receptor EP2/EP3 Market Segment: GPCRs...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Biology Products: